Login to Your Account

Sofinnova Closes $312M 7th Fund; Bets on Life Sciences

By Cormac Sheridan
Staff Writer

Tuesday, December 11, 2012
Europe's cash-starved biotechnology sector has another €240 million (US$312 million) to aim for, following Sofinnova Partners' successful closing of its seventh fund.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription